US 12,227,538 B2
Glucocorticoid receptor agonists
Donmienne Doen Mun Leung, San Diego, CA (US); Jacqueline Mary Wurst, Indianapolis, IN (US); and James Andrew Jamison, La Jolla, CA (US)
Assigned to Eli Lilly and Company, Indianapolis, IN (US)
Filed by Eli Lilly and Company, Indianapolis, IN (US)
Filed on Mar. 22, 2022, as Appl. No. 17/700,910.
Claims priority of provisional application 63/164,603, filed on Mar. 23, 2021.
Prior Publication US 2022/0306680 A1, Sep. 29, 2022
Int. Cl. C07J 17/00 (2006.01); A61P 17/00 (2006.01)
CPC C07J 17/00 (2013.01) [A61P 17/00 (2018.01); C07J 17/005 (2013.01)] 23 Claims
 
1. A compound of the formula:

OG Complex Work Unit Chemistry
wherein R is hydrogen, —P(═O)(OH)2,

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.